Valuation: Sai Life Sciences Limited

Capitalization 24TCr 250.54Cr 215.44Cr 197.22Cr 186.33Cr 344.32Cr 349.85Cr 2.34TCr 914.89Cr 11TCr 940.16Cr 920.3Cr 40TCr P/E ratio 2026
59.2x
P/E ratio 2027 * 59x
Enterprise value 24TCr 250.64Cr 215.52Cr 197.3Cr 186.41Cr 344.46Cr 349.99Cr 2.34TCr 915.25Cr 11TCr 940.54Cr 920.66Cr 40TCr EV / Sales 2026
9.38x
EV / Sales 2027 * 9.34x
Free-Float
62.01%
Yield 2026 *
-
Yield 2027 * -
1 day+1.41%
1 week+5.15%
Current month+6.72%
1 month+18.96%
3 months+21.23%
6 months+30.60%
Current year+25.64%
1 week 949.3
Extreme 949.3
1,151
1 month 949.3
Extreme 949.3
1,151
Current year 783.85
Extreme 783.85
1,151
1 year 707
Extreme 707
1,151
3 years 636.1
Extreme 636.1
1,151
5 years 636.1
Extreme 636.1
1,151
10 years 636.1
Extreme 636.1
1,151
Manager TitleAgeSince
Chief Executive Officer 55 01/05/2004
Director of Finance/CFO - 21/01/2009
Chief Tech/Sci/R&D Officer - 01/04/2026
Director TitleAgeSince
Director/Board Member 55 01/05/2004
Chairman 75 25/01/1999
Director/Board Member 67 21/05/2024
Change 5d. change 1-year change 3-years change Capi.($)
+1.41%+5.15%+56.05% - 250.54Cr
-0.25%+0.31%+36.39%+130.32% 91TCr
-0.30%-0.48%+49.24%+44.31% 55TCr
-0.68%+1.82%+14.85%+46.30% 38TCr
+0.23%+2.53%+24.56%+13.82% 33TCr
-0.21%+1.25%+32.60%+15.59% 29TCr
+0.63%+2.04%+26.98%+30.49% 29TCr
-1.09%-0.40%+44.93%-2.16% 28TCr
+0.66%+1.12%-36.66%-50.97% 20TCr
+0.25%-1.45%+20.57%+48.41% 18TCr
Average +0.03%+0.92%+26.95%+30.68% 34.06TCr
Weighted average by Cap. -0.28%+1.04%+29.45%+51.73%

Financials

2026 2027 *
Net sales 2.23TCr 23Cr 20Cr 18Cr 17Cr 32Cr 32Cr 215.46Cr 84Cr 1.05TCr 87Cr 85Cr 3.67TCr 2.65TCr 27Cr 24Cr 22Cr 20Cr 38Cr 38Cr 255.61Cr 100.02Cr 1.25TCr 102.79Cr 100.61Cr 4.35TCr
Net income 359.6Cr 3.72Cr 3.2Cr 2.93Cr 2.77Cr 5.12Cr 5.2Cr 35Cr 14Cr 169.76Cr 14Cr 14Cr 591.26Cr 411.13Cr 4.26Cr 3.66Cr 3.35Cr 3.17Cr 5.85Cr 5.94Cr 40Cr 16Cr 194.08Cr 16Cr 16Cr 675.99Cr
Net Debt 9.67Cr 10.01L 9L 8L 7L 13.76L 13.98L 93.43L 36.56L 4.56Cr 37.57L 36.77L 16Cr 502.82Cr 5.21Cr 4.48Cr 4.1Cr 3.87Cr 7.15Cr 7.27Cr 49Cr 19Cr 237.36Cr 20Cr 19Cr 826.74Cr
Logo Sai Life Sciences Limited
Sai Life Sciences Limited is an India-based contract research, development, and manufacturing organization (CRO/CDMO). The Company carries out contract research and manufacturing activities for customers engaged in pharmaceutical and biotechnology industries. It is engaged in offering a range of services tailor-made to the customer's requirements. It provides discovery and chemistry, manufacturing, and controls (CMC) services that span from drug discovery to process development and early-phase supplies, all the way to commercial launch and life cycle management. Its services include Integrated Drug Discovery, Synthetic & medicinal chemistry, Biology, drug metabolism and pharmacokinetics (DMPK), Genotoxicity, General Toxicology and Computational chemistry. Its CMC services include route scouting; process development; analytical development; process safety; stability studies; early and mid-phase supplies; late phase, commercial manufacturing; technology transfer, and technologies.
Employees
3,401
Date Price Change Volume
20/26/20 1,141.30 +1.41% 5,98,845
19/26/19 1,125.40 +1.11% 10,08,355
18/26/18 1,113.00 +2.03% 10,97,952
15/26/15 1,090.90 -1.94% 70,27,861
14/26/14 1,112.50 +2.50% 12,46,170
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,141.30INR
Average target price
1,275.00INR
Spread / Average Target
+11.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. SAILIFE Stock